Jennison Associates’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $25.2M | Sell |
|
|||||
|
2018
Q4 | $30.7M | Sell |
|
|||||
|
2018
Q3 | $29.4M | Buy |
|
|||||
|
2018
Q2 | $19.9M | Sell |
|
|||||
|
2018
Q1 | $16.7M | Buy |
|
|||||
|
2017
Q4 | $15.1M | Buy |
|
|||||
|
2017
Q3 | $16.1M | Buy |
|
|||||
|
2017
Q2 | $11.6M | Buy |
|
|||||
|
2017
Q1 | $15.5M | Buy |
|
|||||
|
2016
Q4 | $8.58M | Buy |
|
|||||
|
2016
Q3 | $5.96M | Sell |
|
|||||
|
2016
Q2 | $3.85M | Sell |
|
|||||
|
2016
Q1 | $3.84M | Buy |
|
|||||
|
2015
Q4 | $13.9M | Buy |
|
|||||
|
2015
Q3 | $15.1M | Buy |
|
|||||
|
2015
Q2 | $19.7M | Buy |
|
|||||
|
2015
Q1 | $8.79M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $3.14M | Buy |
|
|||||
|
2014
Q2 | $4.09M | Sell |
|
|||||
|
2014
Q1 | $3.79M | Buy |
|
|||||
|
2013
Q4 | $2.72M | Sell |
|
|||||
|
2013
Q3 | $3.28M | Buy |
|